摘要
Objective This study aimed to characterize the immunomodulatory effects of combined supplementation with lactoferrin (Lf) and human milk oligosaccharides (HMOs; 2′-FL + LNnT) on immune regulation and intestinal homeostasis in a neonatal rat model. Methods SPF Sprague-Dawley neonatal rats were randomly assigned to four groups (Control, HMOs, Lf, and Lf + HMOs) and received daily oral gavage for 30 days. Measured outcomes included body weight, organ indices, peripheral immune cell subsets, serum inflammatory cytokines, intestinal mucosal immunity markers, gut microbiota composition, and fecal short-chain fatty acid (SCFA) profiles. Results Co-administration of Lf (150 mg/kg), 2′-FL (1 g/kg), and LNnT (0.33 g/kg) significantly increased the spleen index and the proportion of CD4 + T lymphocytes. This combined intervention reduced serum pro-inflammatory cytokines IL-6 and TNF-α, and elevated intestinal mucosal immune markers including secretory immunoglobulin A (sIgA) and rat β-defensin-2 (rBD-2). Gut-microbiota profiling showed enrichment of SCFA-producing genera such as Prevotellaceae and Eubacterium , accompanied by higher fecal concentrations of acetic acid, propionic acid, and isovaleric acid. Correlation analysis demonstrated that Prevotellaceae _UCG_001 and Bacteroides were positively associated with SCFAs and immune factors, and negatively associated with pro-inflammatory cytokines. Conclusion Concurrent supplementation of lactoferrin and HMOs modulates gut microbiota composition and fecal SCFA levels, and exerts marker-dependent regulatory effects on systemic and mucosal immunity in neonatal rats. The observed associations among gut microbiota, SCFAs and host immune phenotypes provide pre-clinical evidence supporting further investigation of combined Lf and HMOs supplementation as a nutritional strategy for promoting early-life gut health and immune maturation.
危险品化学品经营许可证(带存储)